IDYAIDEAYA Biosciences, Inc.
39.67USD+2.06%Mkt Cap: 3.83B $P/E: —3d ago
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral,…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.83B $
Enterprise Value2.97B $
Revenue (TTM)234.13M $
Gross Profit-85.24M $
Net Income (TTM)-113.70M $
Revenue/Share2.617 USD
Last Price39.67 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees145
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45166A1025
Valuation
P/E (Trailing)—
P/E (Forward)-9.52
PEG—
EV/EBITDA-13.88
EV/Revenue12.70
P/S16.12
P/B3.14
EPS (TTM)-1.93
EPS (Forward)-4.11
52W Range
23.2395% of range40.58
52W High40.58 USD
52W Low23.23 USD
Profitability
Gross Margin-36.41%
Oper. Margin-1380.73%
EBITDA Margin-91.49%
Profit Margin-51.99%
ROE-11.11%
ROA-10.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.10M $
CapEx (TTM)2.37M $
FCF Margin-30.26%
FCF Yield-1.85%
Net Debt-799.65M $
Net Debt/EBITDA3.73
Balance Sheet
Debt/Equity0.03
Current Ratio10.45
Quick Ratio10.21
Book Value/Sh12.44 USD
Cash/Share8.591 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)52.15 USD
Upside (mean)+31.5%
Target Range31.00 USD – 65.00 USD
$31.00+31.5% to mean$65.00
# Analysts13
Ownership
Shares Out.96.49M
Float90.63M
Insiders2.19%
Institutions108.18%
Short Interest
Short Ratio10.4d
Short % Float12.21%
Short % Out.10.50%
Shares Short10.11M
Short (prev mo.)10.33M
Technical
SMA 5035.67 (+11.2%)
SMA 20033.22 (+19.4%)
Beta-0.09
S&P 52W Chg18.16%
Avg Vol (30d)706.97K
Avg Vol (10d)684.14K
Technical Indicators
RSI (14)68.2
MACD0.7447
MACD Signal0.5374
MACD Hist.+0.2073
BB Upper38.69 USD
BB Middle36.57 USD
BB Lower34.46 USD
BB Width11.56%
ATR (14)1.408 USD
Vol Ratio (20d)1.23x